INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 142 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2019. The put-call ratio across all filers is 2.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,726 | +8.0% | 5,754 | +31.3% | 0.00% | – |
| Q2 2023 | $277,405 | -13.0% | 4,381 | -52.9% | 0.00% | -100.0% |
| Q4 2019 | $319,000 | +20.4% | 9,300 | -54.5% | 0.00% | 0.0% |
| Q2 2019 | $265,000 | +6.4% | 20,425 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $249,000 | +9.2% | 20,425 | +2.1% | 0.00% | 0.0% |
| Q4 2018 | $228,000 | +1972.7% | 20,000 | +2122.2% | 0.00% | – |
| Q2 2017 | $11,000 | -26.7% | 900 | 0.0% | 0.00% | – |
| Q1 2017 | $15,000 | +1400.0% | 900 | +1536.4% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 55 | -57.7% | 0.00% | – |
| Q3 2016 | $2,000 | – | 130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |